High-Energy Proton Testing of Sensitive Electronics for use on Modular Infrared Molecules and Ices Sensor (MIRMIS) Instrument

The Comet Interceptor (CI) mission is ESA\u27s first F class mission, selected in June 2019. This mission consists of three spacecraft: Spacecraft A (main spacecraft), Spacecraft B1 (supplied by the Japanese space agency JAXA), and Spacecraft B2. In this paper, we highlight the Modular Infrared Molecular and Ices Sensor (MIRMIS) instrument, which is integrated into the CI Spacecraft A\u27s scientific payload. In addition to hardware contributions from Finland (VTT Finland) and the UK (University of Oxford), the MIRMIS instrument team includes members from the University of Helsinki and NASA\u27s Goddard Space Flight Centre. MIRMIS covers the spectral range of 0.9 to ~25 μm. This paper presents the preliminary high-proton-energy radiation test results of MIRMIS’ near-infrared detector arraysensitive electronic components. Proton beam testing is performed to estimate Single Event Effects (SEE) on the PCB boards and SEE and Total Non-Ionizing Dose (TNID)/ Displacement Damage (DD) on the detectors. The tests were conducted at the Paul Scherrer Institute (PSI) Proton Irradiation Facility (PIF), Villigen, Switzerland. The levels for the tests were based on the mission requirements for the ESA Comet Interceptor mission: 3 years (at 1 AU- Segment 1) and 2 years (at 0.9 AU- Segment 2). The DD levels from the analysis were equivalent to 1e11 protons/cm2 with an energy of 50 MeV. The electronics are exposed to high-energy protons causing Single Event Effects (SEE) which may induce potentially destructive and non-destructive effects. The test items primarily included the InGaAs image sensors (SCD Cardinal640, standard and low noise), Xilinx Spartan-6 FPGAs (Field Programmable Gate Arrays), and other proximity electronics. The proton energies were varied from 50 to 200 MeV, at fluxes of 106 to 108 particles/cm2/s. No events were observed on the standard Cardinal640 sensor at target fluences between 1.00E+10 to 1.00E+11 particles/cm2. FPGAs did not show any susceptibility to TNID at fluences up to 1.00E+11 (particles/cm2)

Code status documentation at admission in COVID-19 patients: a descriptive cohort study

Objectives The COVID-19 pandemic pressurised healthcare with increased shortage of care. This resulted in an increase of awareness for code status documentation (ie, whether limitations to specific life-sustaining treatments are in place), both in the medical field and in public media. However, it is unknown whether the increased awareness changed the prevalence and content of code status documentation for COVID-19 patients. We aim to describe differences in code status documentation between infectious patients before the pandemic and COVID-19 patients. Setting University Medical Centre of Utrecht, a tertiary care teaching academic hospital in the Netherlands. Participants A total of 1715 patients were included, 129 in the COVID-19 cohort (a cohort of COVID-19 patients, admitted from March 2020 to June 2020) and 1586 in the pre-COVID-19 cohort (a cohort of patients with (suspected) infections admitted between September 2016 to September 2018). Primary and secondary outcome measures We described frequency of code status documentation, frequency of discussion of this code status with patient and/or family, and content of code status. Results Frequencies of code status documentation (69.8% vs 72.7%, respectively) and discussion (75.6% vs 73.3%, respectively) were similar in both cohorts. More patients in the COVID-19 cohort than in the before COVID-19 cohort had any treatment limitation as opposed to full code (40% vs 25%). Within the treatment limitations, 'no intensive care admission' (81% vs 51%) and 'no intubation' (69% vs 40%) were more frequently documented in the COVID-19 cohort. A smaller difference was seen in 'other limitation' (17% vs 9%), while 'no resuscitation' (96% vs 92%) was comparable between both periods. Conclusion We observed no difference in the frequency of code status documentation or discussion in COVID-19 patients opposed to a pre-COVID-19 cohort. However, treatment limitations were more prevalent in patients with COVID-19, especially 'no intubation' and 'no intensive care admission'.Pathophysiology, epidemiology and therapy of agein

Long-term changes in drought indices in eastern and central Europe

This study analyses long-term changes in drought indices (Standardised Precipitation Index—SPI, Standardised Precipitation–Evapotranspiration Index—SPEI) at 1 and 3 months scales at 182 stations in 11 central and eastern European countries during 1949–2018. For comparative purposes, the necessary atmospheric evaporative demand (AED) to obtain SPEI was calculated using two methods, Hargreaves-Samani (SPEIH) and Penman-Monteith (SPEIP). The results show some relevant changes and tendencies in the drought indices. Statistically significant increase in SPI and SPEI during the cold season (November–March), reflecting precipitation increase, was found in the northern part of the study region, in Estonia, Latvia, Lithuania, northern Belarus and northern Poland. In the rest of study domain, a weak and mostly insignificant decrease prevailed in winter. Summer season (June–August) is characterized by changes in the opposite sign. An increase was observed in the north, while a clear decrease in SPEI, reflecting a drying trend, was typical for the southern regions: the Czech Republic, Slovakia, Hungary, Romania, Moldova and southern Poland. A general drying tendency revealed also in April, which was statistically significant over a wide area in the Czech Republic and Poland. Increasing trends in SPI and SPEI for September and October were detected in Romania, Moldova and Hungary. The use of SPEI instead of SPI generally enhances drying trends

Lipid rafts are essential for release of phosphatidylserine-exposing extracellular vesicles from platelets.

Platelets protect the vascular system during damage or inflammation, but platelet activation can result in pathological thrombosis. Activated platelets release a variety of extracellular vesicles (EVs). EVs shed from the plasma membrane often expose phosphatidylserine (PS). These EVs are pro-thrombotic and increased in number in many cardiovascular and metabolic diseases. The mechanisms by which PS-exposing EVs are shed from activated platelets are not well characterised. Cholesterol-rich lipid rafts provide a platform for coordinating signalling through receptors and Ca2+ channels in platelets. We show that cholesterol depletion with methyl-β-cyclodextrin or sequestration with filipin prevented the Ca2+-triggered release of PS-exposing EVs. Although calpain activity was required for release of PS-exposing, calpain-dependent cleavage of talin was not affected by cholesterol depletion. P2Y12 and TPα, receptors for ADP and thromboxane A2, respectively, have been reported to be in platelet lipid rafts. However, the P2Y12 antagonist, AR-C69931MX, or the cyclooxygenase inhibitor, aspirin, had no effect on A23187-induced release of PS-exposing EVs. Together, these data show that lipid rafts are required for release of PS-exposing EVs from platelets.Isaac Newton Trust/ Wellcome Trust ISSF/University of Cambridge Joint Research Grant British Heart Foundation grant SP/15/7/3156

Factors associated with the timing of introduction of complementary feeding: the Generation R Study

Background/objectives:Many parents do not follow recommendations for the timing of introduction of complementary feeding. The aim of this study was to identify determinants associated with the timing of introduction of complementary feeding in a multiethnic birth cohort.Subjects/methods:Subjects were 3561 mothers and infants participating in a prospective cohort study. The timing of introduction of complementary feeding and maternal and infant characteristics were obtained by parent-derived questionnaires. Regression analyses were performed to identify determinants for the timing of introduction of complementary feeding (<3, 3-6 and ≥6 months).Results:In total, 62% of infants were introduced to complementary feeding before the age of 6 months. Determinants for very early (<3 months) introduction were being a single parent and infant day care attendance. Determinants for early (3-6 months) introduction were young maternal age, multiple parities, no infant family history of asthma, atopy and no infant history of allergy to cow's milk. Determinants for both very early and early introduction were low educational level and not fully breastfeeding for 4 months. Maternal educational level was only significantly associated with the timing of introduction in mothers of Western origin.Conclusions:This study confirmed determinants for the timing of introduction of complementary feeding that have been identified by previous studies, which may be appropriate targets for education and guidance. Moreover, mothers whose infants attend day care and have a family history of asthma, atopy or allergy to cow's milk may need guidance to follow infant feeding recommendations. © 2013 Macmillan Publishers Limited All rights reserved